Editors' picks from other sources

Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

TB vaccine news

Show

From To
Vaccines
Injection-free vaccination technique could address global vaccine challenge for diseases such as HIV and malaria

Scientists at King’s College London have demonstrated the ability to deliver a dried live vaccine to the skin without a traditional needle, and shown for the first time that this technique is powerful enough to enable specialised immune cells in the skin to kick-start the immunising properties of the vaccine.

Published
11 February 2013
From
Kings College London press release
TB vaccine
Data from Historic Phase IIb Clinical Trial for Tuberculosis Vaccine Candidate MVA85A Published in The Lancet

Vaccine candidate did not provide statistically-significant protection in preventing TB disease in infants previously vaccinated with BCG.

Published
04 February 2013
From
Aeras
TB vaccine
TB Vaccine Safe but Does Not Confer Protection, Calls for Redoubling Efforts on Global TB Vaccine Portfolio

The clinical trial of the TB vaccine candidate MVA85A was a Phase IIb safety and efficacy trial in 2,797 infants living in the Western Cape province of South Africa. The candidate was safe and well tolerated in the population tested.

Published
04 February 2013
From
Aeras
TB vaccine
Revived search for a TB vaccine may be about to pay off

After nearly 100 years, researchers could be on the verge of finding a vaccine that would eradicate tuberculosis infections, a scourge that kills 1.4 million people a year.

Published
04 February 2013
From
Reuters
HEALTH: New TB vaccine on the horizon

A research team at Oxford University in the UK is very close to determining the efficacy of their new tuberculosis (TB) vaccine. If current clinical trials are successful, it will be the first new TB vaccine in almost a century.

Published
17 October 2012
From
IRIN Plus News
TB vaccine
Green light for start clinical trials of innovative and promising tuberculosis vaccine

European scientists are one step closer to delivering a new, safe and more effective vaccine against tuberculosis. Swiss-medic, the Swiss regulatory authority for medicine has given permission to start assessing the new TB vaccine in healthy adult volunteers. The vaccine, called MTBVAC, is the first vaccine of its kind to start clinical evaluation.

Published
17 October 2012
From
TB vaccine Initiative
TB vaccine
Aeras signs agreement with GSK to jointly advance TB vaccine

Aeras announces that it has signed an agreement with GlaxoSmithKline Vaccines, S.A. (GSK) to jointly advance the clinical development of an investigational tuberculosis (TB) vaccine containing GSK's proprietary M72 antigen and AS01E* adjuvant.

Published
10 October 2012
From
Eurekalert Medicine & Health
TB vaccine
Einstein awarded $6 million grant to develop new TB vaccine against drug-resistant strains

The National Institutes of Health has awarded researchers at Albert Einstein College of Medicine at Yeshiva University a five-year, $5.9 million grant to develop a new vaccine against tuberculosis, including the toughest-to-treat forms of the disease known as multi drug-resistant and extensively drug-resistant.

Published
31 May 2012
From
Eurekalert Inf Dis
Vaccines
Experts, Advocates Urge Continued Funding For Research Into HIV, TB Vaccines

"[P]articipants at a symposium held last week by the U.K. Consortium on AIDS and International Development warned that [progress on HIV and tuberculosis (TB) vaccines] could be jeopardized by the recent downturn in global health funding," BMJ reports.

Published
23 May 2012
From
Kaiser Daily Global Health Policy Report
TB vaccine
PDPs agree to jointly develop new TB vaccine candidate

Aeras and the Infectious Disease Research Institute (IDRI) – two non-profit product development partnerships (PDPs) – announced Wednesday they will be joining together to develop IDRI’s novel tuberculosis (TB) vaccine candidate ID93/GLA-SE.

Published
10 May 2012
From
Science Speaks
← First123Next →

Filter by country